simvastatin

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instanceOf gptkb:drug
statin
gptkbp:approvalYear 1991
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode C10AA01
gptkbp:bioavailability less than 5%
gptkbp:brand gptkb:Zocor
gptkbp:CASNumber 79902-63-9
gptkbp:chemicalFormula C25H38O5
gptkbp:contraindication pregnancy
active liver disease
gptkbp:developedBy gptkb:lovastatin
gptkbp:discoveredBy gptkb:Merck_&_Co.
gptkbp:drugClass lipid-lowering agent
gptkbp:eliminationHalfLife 2 hours
gptkbp:essentialMedicine gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:excretion urine
feces
gptkbp:firstSynthesized 1980s
https://www.w3.org/2000/01/rdf-schema#label simvastatin
gptkbp:interactsWith gptkb:milk
gptkb:cyclosporine
gptkb:warfarin
gptkb:gemfibrozil
gptkb:erythromycin
gptkbp:IUPACName (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction HMG-CoA reductase inhibitor
gptkbp:meltingPoint 135°C
gptkbp:metabolism gptkb:CYP3A4
gptkbp:pregnancyCategory gptkb:X_(US)
gptkbp:proteinBinding 95%
gptkbp:PubChem_CID 54454
DB00641
gptkbp:riskFactor hepatotoxicity
muscular dystrophy
rhabdomyolysis
gptkbp:routeOfAdministration oral
gptkbp:sideEffect muscle pain
digestive problems
liver enzyme abnormalities
gptkbp:UNII AGG2FN16EV
gptkbp:usedFor lowering cholesterol
prevention of cardiovascular disease
gptkbp:bfsParent gptkb:CYP3A4
gptkb:Vytorin
gptkb:Zocor
gptkbp:bfsLayer 5